Application 076154
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LORATADINE | LORATADINE | TABLET;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076154-001 | LORATADINE | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine | LORATADINE | Safecor Health, LLC | 14d1ecf5-d694-4ce0-87e4-df27f3f4d909 | 2026-03-31 | Warnings | 076154 ANDA076154 |
| Loratadine | LORATADINE | Mylan Institutional Inc. | 1fc9ddd1-393d-4fe2-a9e0-d192df7331db | 2025-07-22 | Warnings | 076154 ANDA076154 51079-246 |
| Loratadine | LORATADINE | Mylan Pharmaceuticals Inc. | 3b307aea-5a68-4c82-959a-cda4ffbd0a4a | 2013-11-15 | Warnings | 076154 ANDA076154 0378-8880 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-8880 | Loratadine | loratadine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 51079-246 | Loratadine | loratadine | Mylan Institutional Inc. | ANDA | Current |
| 51079-246 | Loratadine | loratadine | Mylan Institutional Inc. | ANDA | Current |
| 55154-4375 | Loratadine | loratadine | Cardinal Health 107, LLC | ANDA | Current |
| 55154-4375 | Loratadine | loratadine | Cardinal Health | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8871 | ORIG | 2003-04-11 |